Market News

EPS for Equity Commonwealth (EQC) Expected At $0.20; Palo Alto Investors Has Lowered Its Gilead Sciences (GILD) Position

Palo Alto Investors Llc decreased Gilead Sciences Inc (GILD) stake by 49.97% reported in 2017Q3 SEC filing. Palo Alto Investors Llc sold 175,700 shares as Gilead Sciences Inc (GILD)’s stock declined 8.05%. The Palo Alto Investors Llc holds 175,900 shares with $14.25M value, down from 351,600 last quarter. Gilead Sciences Inc now has $105.53 billion valuation. The stock increased 0.81% or $0.65 during the last trading session, reaching $80.79. About 6.60 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has declined 21.80% since February 14, 2017 and is downtrending. It has underperformed by 38.50% the S&P500.

Analysts expect Equity Commonwealth (NYSE:EQC) to report $0.20 EPS on February, 21.They anticipate $0.03 EPS change or 13.04% from last quarter’s $0.23 EPS. EQC’s profit would be $24.82M giving it 35.80 P/E if the $0.20 EPS is correct. After having $0.22 EPS previously, Equity Commonwealth’s analysts see -9.09% EPS growth. The stock decreased 0.56% or $0.16 during the last trading session, reaching $28.64. About 873,323 shares traded or 41.96% up from the average. Equity Commonwealth (NYSE:EQC) has risen 13.35% since February 14, 2017 and is uptrending. It has underperformed by 3.35% the S&P500.

Among 3 analysts covering Equity Commonwealth (NYSE:EQC), 1 have Buy rating, 0 Sell and 2 Hold. Therefore 33% are positive. Equity Commonwealth had 9 analyst reports since August 10, 2015 according to SRatingsIntel. The rating was upgraded by Citigroup to “Neutral” on Monday, September 14. The firm has “Neutral” rating given on Friday, September 11 by Citigroup. As per Thursday, September 1, the company rating was maintained by Citigroup. The stock has “Hold” rating by Stifel Nicolaus on Monday, September 18. On Monday, August 15 the stock rating was upgraded by Bank of America to “Buy”. The rating was maintained by Stifel Nicolaus on Friday, July 14 with “Hold”. The firm has “Sell” rating by Zacks given on Monday, August 10. The firm has “Neutral” rating by Bank of America given on Wednesday, September 9. Stifel Nicolaus downgraded Equity Commonwealth (NYSE:EQC) on Friday, November 6 to “Hold” rating.

Equity Commonwealth is a Chicago based, internally managed and self-advised real estate investment trust (REIT) with commercial office properties throughout the United States. The company has market cap of $3.55 billion.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 124 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was upgraded by BMO Capital Markets on Wednesday, November 2 to “Outperform”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Monday, October 16 by Robert W. Baird. The company was maintained on Friday, October 27 by BMO Capital Markets. The stock has “Equal-Weight” rating by Morgan Stanley on Thursday, May 26. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Citigroup on Friday, April 29. The rating was maintained by Robert W. Baird on Friday, September 15 with “Buy”. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Buy” rating by Maxim Group on Thursday, November 30. The stock has “Buy” rating by Mizuho on Tuesday, July 25. As per Tuesday, September 6, the company rating was upgraded by Jefferies. The rating was initiated by Citigroup on Thursday, February 25 with “Buy”.

Since August 30, 2017, it had 0 buys, and 13 sales for $51.09 million activity. Shares for $2.08M were sold by Alton Gregg H. 73,333 shares valued at $6.05 million were sold by MARTIN JOHN C on Monday, October 2. Another trade for 100,000 shares valued at $8.02 million was sold by Meyers James R. The insider Washington Robin L sold $4.40 million.

Leave a Reply

Your email address will not be published. Required fields are marked *